Xuanyi Nie

Dr. Xuanyi Nie

Harvard University Graduate School of Design
+1
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

20 May 2024 in Applied Geography
Verified
Journal Article
Closed access
YZYichun Zhou
Yichun Zhou
ChengHe GuanChengHe Guan
ChengHe Guan
LWLongfeng Wu
Longfeng Wu
YLying li
ying li
XNXuanyi Nie
Xuanyi Nie
Yuki AkiyamaYuki Akiyama
Yuki Akiyama


20 September 2020 in Sustainability
Verified
Journal Article
Open access
PDF file
HFHaobin Bruce Fan
Haobin Bruce Fan
XNXuanyi Nie
Xuanyi Nie
This study evaluates the impact of unemployment and government financial assistance during the COVID-19 pandemic on the working-age population’s mental health and further examines the differential impacts between urban and non-urban groups, as well as African American (AA) and non-African American groups. Based on the COVID-19 Household Impact Survey, four measures of mental health conditions (nervous, depressed, lonely, and hopeless) are constructed. Our empirical analysis applies the ordinal regression model (ordered logit model) that takes both the week and regional factors into consideration to control for potential time effects and time-invariant confounders varying across regions. The results show that government aid only mitigates the psychological symptoms for the group in non-urban areas, with no significant impacts on the urban group. On the other hand, the AA working-age group experiences similar or more favorable mental health than other ethnic groups, while government aid does not alleviate the mental pressure for the AA group. Therefore, government interventions should recognize the heterogeneity of impacts on socioeconomic groups within the target population.

29 November 2022 in Urban Studies
Verified
Journal Article
Closed access
XNXuanyi Nie
Xuanyi Nie
The role of hospitals has significantly changed over the past decades and the ‘medical city’ has emerged as a new urban phenomenon in China. However, research on the significance of the medical city to China’s urbanism is limited. This paper situates China’s medical city in the theory of state entrepreneurialism and rethinks consumerism in healthcare. Particularly focussing on the state–market and production–consumption dyads, the paper argues that the state has engineered the institutional and market legitimacy for the rise of consumerism in healthcare and allows the medical city to capitalise on the provision and consumption of high-end healthcare services to advance the healthcare reform and capture economic opportunities. This argument is substantiated by a case study on the Shanghai New Hongqiao International Medical Center, which focusses on the public–private partnerships in the medical city. It is found that while the production of the medical city is based on private sector participation, the state’s presence is diffused in the governance of the medical city through public–private partnerships, which reflect the characteristics of state entrepreneurialism. The findings add to the theory of China’s urbanism with new sets of materials and render important implications for the urban future in China.

5 May 2023 in Regional Studies
Verified
Journal Article
Closed access
XNXuanyi Nie
Xuanyi Nie
HLHaijing Liu
Haijing Liu
Concerning China’s growth in biotechnology, the research on biotech start-ups in China yields significant implications. However, studies have not given enough attention to hospitals, which are critical players in the biotech industry. Because of the hospital-centric healthcare system, public tertiary hospitals in China are important partners for biotech start-ups. This study investigates the geographical relationship between public tertiary hospitals and biotech start-ups in Chinese cities. The findings suggest evidence of collocation, which reflects their alliances. This research thereby contributes to the existing knowledge of the biotech industry by integrating the healthcare system into the location of biotech firms.